Pfizer To Allow Its COVID-19 Pill To Be Sold Cheaply
Provided By - Video Elephant on November 16, 2021
Pfizer has announced that it will allow its COVID-19 pill to be made and sold cheaply in developing countries.
The company has agreed to allow the COVID-19 treatment to be made and sold inexpensively in 95 developing nations.
Under the agreement, Pfizer will grant a royalty-free license for the drug to the Medicines Patent Pool.
The United Nations-backed nonprofit will sell the formula for use in 95 developing countries.
The agreement follows a similar deal made by Merck for their COVID-19 pill.
Merck is allowing its antiviral pill, molnupiravir, to be made and sold inexpensively in 105 developing countries.
The two deals could have a major impact on the pandemic by preventing severe illness from the coronavirus.